Aptevo Therapeutics Inc (APVO)
Drugs • Health Care
Percentage
Change
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 23 | Mar 24 | Feb 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -24 | -28 | ||||||||
Preferred Dividends | 0 | 2 | ||||||||
Net Income | -24 | -26 | ||||||||
Profit | -24 | -26 | ||||||||
Net Income Continuing | -24 | -26 | ||||||||
Pretax Income | -24 | -26 | ||||||||
Total Non-operating Income | 0 | 0 | ||||||||
Operating Income | -25 | -26 | ||||||||
Total Costs and Expenses | -25 | -26 | ||||||||
Operating Expenses | -25 | -26 | ||||||||
Research and Development Expenses | -14 | -15 | ||||||||
Selling, General & Administrative Expenses | -10 | -12 |